Last 2.51 INR
Change Today +0.04 / 1.62%
Volume 3.6K
SBIL On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

saamya biotech india ltd (SBIL) Snapshot

Open
2.51
Previous Close
2.47
Day High
2.51
Day Low
2.51
52 Week High
07/9/14 - 2.87
52 Week Low
04/16/14 - 0.98
Market Cap
62.5M
Average Volume 10 Days
20.0K
EPS TTM
0.04
Shares Outstanding
24.9M
EX-Date
--
P/E TM
65.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for SAAMYA BIOTECH INDIA LTD (SBIL)

Related News

No related news articles were found.

saamya biotech india ltd (SBIL) Related Businessweek News

No Related Businessweek News Found

saamya biotech india ltd (SBIL) Details

Saamya Biotech (India) Limited, a biotechnology company, focuses on the manufacture and marketing of biopharmaceuticals and recombinant protein products. The company was incorporated in 2002 and is based in Hyderabad, India.

Founded in 2002

saamya biotech india ltd (SBIL) Top Compensated Officers

Chairman and Joint Managing Director
Total Annual Compensation: 300.0K
Managing Director, Executive Director, Member...
Total Annual Compensation: 300.0K
Compensation as of Fiscal Year 2013.

saamya biotech india ltd (SBIL) Key Developments

Saamya Biotech (India) Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014

Saamya Biotech (India) Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported net sales of INR 133.6 million, profit from operations before other income, interest and exceptional items of INR 4.9 million, profit from ordinary activities before tax of INR 4.9 million and net profit of INR 4.3 million or INR 0.17 per diluted share compared to loss from operations before other income, interest and exceptional items of INR 2.5 million, loss from ordinary activities before tax of INR 2.4 million and net loss of INR 2.3 million or INR 0.09 per diluted share reported in the same period last year. For the year, the company reported net sales of INR 133.6 million, profit from operations before other income, interest and exceptional items of INR 1.65 million, profit from ordinary activities before tax of INR 1.5 million and net profit of INR 1 million or INR 0.04 per diluted share compared to loss from operations before other income, interest and exceptional items of INR 3.9 million, loss from ordinary activities before tax of INR 4.1 million and net loss of INR 4 million or INR 0.16 per diluted share reported in the same period last year.

Saamya Biotech (India) Limited, Board Meeting, May 30, 2014

Saamya Biotech (India) Limited, Board Meeting, May 30, 2014. Agenda: To consider audited standalone earnings results for the fourth quarter and full year ended March 31, 2014.

Saamya Biotech (India) Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Saamya Biotech (India) Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, loss from operations before other income, finance costs and exceptional items was INR 839,239 compared to loss from operations before other income, finance costs and exceptional items of INR 762,494 a year ago. Loss from ordinary activities before tax was INR 852,910 compared to loss ordinary activities before tax of INR 805,612 a year ago. Loss for the period was INR 850,758 or INR 0.03 per basic and diluted share compared to loss for the period of INR 733,567 or INR 0.03 per basic and diluted share a year ago. For the nine months, loss from operations before other income, finance costs and exceptional items was INR 3,237,919 compared to loss from operations before other income, finance costs and exceptional items of INR 1,413,862 a year ago. Loss from ordinary activities before tax was INR 3,336,668 compared to loss ordinary activities before tax of INR 1,639,917 a year ago. Loss for the period was INR 3,330,006 or INR 0.13 per basic and diluted share compared to loss for the period of INR 1,673,052 or INR 0.07 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBIL:IN 2.51 INR +0.04

SBIL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SBIL.
View Industry Companies
 

Industry Analysis

SBIL

Industry Average

Valuation SBIL Industry Range
Price/Earnings 61.5x
Price/Sales 0.5x
Price/Book 0.2x
Price/Cash Flow 28.6x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAAMYA BIOTECH INDIA LTD, please visit www.saamyabiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.